Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1

Clinical trial NCT00032929 · COMPLETED

Trial details

NCT number: NCT00032929
Sponsor: National Institute on Drug Abuse (NIDA)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cocaine-Related Disorders

Start date: 2001-03-01
Primary completion: 2002-12-01
Enrollment: 269

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.